openPR Logo
Press release

Biologics Contract Manufacturing Market - Forecasts to 2026

Biologics Contract Manufacturing Market

Biologics Contract Manufacturing Market

The findings reviewed by GME stated that the Global Biologics Contract Manufacturing Market will expand with a CAGR value 8.2%. Increasing incidences of cancer and other chronic diseases have increased the demand for pharmaceutical drugs in the market. Increased production costs due to government regulations on clinical trials and other costs have resulted in pharmaceutical companies outsourcing production from development stages to drug dose selection to manufacturing to packaging.

Browse 159 Market Data Tables and 119 Figures spread through 189 Pages and in-depth TOC on "Biologics Contract Manufacturing Market - Forecast to 2026" https://www.globalmarketestimates.com/market-report/global-biologics-contract-manufacturing-market-2773

By Product (Monoclonal Antibodies, Vaccines, Growth Factors, Interferons, Recombinant Hormones, Insulin, Others), By Platform (Mammalian, Microbial), By Application (Clinical, Commercial),By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis
Key Market Insights
• Biologics are bioengineered protein-based drugs that are sourced from organic materials like mammalian and microbial sources.
• The pharmaceutical companies outsource drug production to biologic contract manufacturing vendors due to increasing drug production cost.
• In terms of market value or revenue, the largest shareholder as per platform outlook was the microbial segment in 2020.
• Lonza Group, BioXcellence, AG Samsung Biologics Co. Ltd., AbbVie Contract Manufacturing, Fujifilm Diosynth Biotechnologies (FUJIFILM Holdings), WuXi Biologics Inc., AGC Biologics, Ajinomoto Bio-Pharma, Patheon N.V., Emergent BioSolutions Inc., Avid Bioservices Inc., Catalent Inc., KBI Biopharma, and Abzena Plc, among others, are the major vendors competing in the biologics contract manufacturing market.

Browse the Report @ https://www.globalmarketestimates.com/market-report/global-biologics-contract-manufacturing-market-2773

Product Outlook (Revenue, USD Billion, 2021-2026)
• Monoclonal Antibodies
• Vaccines
• Growth Factors
• Interferons
• Recombinant Hormones
• Insulin
• Others

Platform Outlook (Revenue, USD Billion, 2021-2026)
• Mammalian
• Microbial

Application Outlook (Revenue, USD Billion, 2021-2026)
• Clinical
• Commercial

Regional Outlook (Revenue, USD Billion, 2021-2026)
North America
• The U.S.
• Canada
• Mexico
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Rest of APAC
Central & South America
• Brazil
• Argentina
• Rest of CSA
Middle East & Africa
• Saudi Arabia
• UAE
• Rest of MEA

Contact: Tracy Simon
Email address: tracy.simon@globalmarketestimates.com
Phone Number: +16026667238
Website: Global Market Estimates

B-502, Kemp Plaza, Mindspace, Malad West, Mumbai: 400 064, India

Global Market Estimates is an India based market research and consulting company. The company provides syndicated research reports, customised research reports and consulting services to their clients and helps them achieve their business goals on a commercial level. Global Market Estimates database is used by the world's well known and prolific academic institutions and Fortune 500 companies to understand the global and regional business environment to excel in their business goals.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biologics Contract Manufacturing Market - Forecasts to 2026 here

News-ID: 2249897 • Views:

More Releases from Global Market Estimates Research & Consultants

Global Flare Monitoring Market Size & Trends
Global Flare Monitoring Market Size & Trends
According to a new market research report published by Global Market Estimates, the global flare monitoring market is expected to grow at a CAGR of 6.5% from 2024 to 2029. Global flare monitoring market growth is driven by factors such as safety and risk management and growing emphasis on reduction of emissions. Unlock the Executive Summary of the report at only USD 249. Book a call now: https://tidycal.com/yashsushiljain/unlock-strategic-insights-press-release Key Market Insights • As per
Global Fiber Optic Component System Market Size & Trends
Global Fiber Optic Component System Market Size & Trends
According to a new market research report published by Global Market Estimates, the global fiber optic component system market is expected to grow at a CAGR of 8.46 % from 2024 to 2029. Global fiber optic component system market growth is driven by factors such as growing demand for safety regulations and technological developments. Unlock the Executive Summary of the report at only USD 249. Book a call now: https://tidycal.com/yashsushiljain/unlock-strategic-insights-press-release Key Market
Global Rechargeable Battery Market Size & Trends
Global Rechargeable Battery Market Size & Trends
According to a new market research report published by Global Market Estimates, the global rechargeable battery market is expected to grow at a CAGR of 15.4% from 2024 to 2029. Rechargeable batteries have been growing in popularity due to their inherent superiority over disposable batteries in environmental pollution. As rechargeable batteries can be recharged after every use, they cause much lower environmental degradation as compared to disposable batteries, which are discarded
Global Asset Management Solution Market Size & Trends
Global Asset Management Solution Market Size & Trends
According to a new market research report published by Global Market Estimates, the global asset management solution market is projected to grow at a CAGR of 35.1% from 2024 to 2029. The growth of the global asset management solution market is driven by increasing demand for efficient and automated asset tracking and management, the growing need for compliance and risk management in various industries (IoT), and the expanding adoption of cloud-based

All 5 Releases


More Releases for Biologics

Biopharmaceutical CMO Market 2020 Business Scenario – Lonza, Boehringer Ingelh …
The report provides a valuable source of insightful data for business strategists and competitive analysis of Biopharmaceutical CMO Market. It provides the Biopharmaceutical CMO industry overview with growth analysis and futuristic cost, revenue and many other aspects. The research analysts provide an elaborate description of the value chain and its distributor analysis. This Tire Biopharmaceutical CMO study provides comprehensive data which enhances the understanding, scope and application of this report. the
Extracellular Matrix Market Detailed Analysis 2020: Top Companies like Coloplast …
The global extracellular matrix market by raw material segments was led by porcine segment. In 2018, the porcine segment held a largest market share of 41.09% of the extracellular matrix market, by raw material. However, the bovine segment is expected to be the fastest growing segments of the market in 2027 owing to more beneficial properties to treat various conditions which is expected to become the major factor for the
Biopharmaceutical CMO Market 2018-2023 :Lonza, Boehringer Ingelheium, Samsung Bi …
Global Biopharmaceutical CMO Industry - A Global Market Overview (2018-2023) (Avail A 10% Off) The "Global Biopharmaceutical CMO Market Research Report 2018-2023" is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides
Global Biopharmaceutical CMO Market Key Profiles - Wuxi Biologics, Boehringer In …
Global Biopharmaceutical CMO Market was valued at USD 13296.29 million in the year 2019. Escalating number of patients suffering from various diseases with growing investment in the healthcare industry by government in major economies and increasing awareness among consumers regarding impact of various viruses on health, has been anticipated to infuse growth in the market for Biopharmaceutical CMO during the forecasting period of 2020-2025. Get Free Sample Copy of this Research
Plant-based Biologics
Increasing demand for biologics for various chronic diseases and rising investment in R&D for the production of biologics is expected to contribute significantly to the growth of plant-based biologics market. According to Biotechnology Innovation Organization (BIO) 2015, over 250 biologic therapies and vaccines have changed the lives of hundreds of millions of patients. Moreover, according to the same source, over 900 biologics are currently (2018) under the stage of development
Global Biopharmaceutical CMO Market 2018-2023| Lonza, Boehringer Ingelheium, Sam …
Albany, NY, 10th September : Recent research and the current scenario as well as future market potential of "Global Biopharmaceutical CMO Market - Analysis By Region, By Country: Opportunities and Forecast (2018-2023) - By Region (North America, Europe, APAC), By Country (U.S, Denmark, Germany, Switzerland, Korea, Japan, China)" globally. A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to